Patel Divya A, Barnholtz-Sloan Jill S, Patel Mehul K, Malone John M, Chuba Paul J, Schwartz Kendra
Wayne State University School of Medicine and Karmanos Cancer Institute, Detroit, MI 48201, USA.
Gynecol Oncol. 2005 May;97(2):550-8. doi: 10.1016/j.ygyno.2005.01.045.
The incidence of cervical cancer is higher in Hispanic than in non-Hispanic or African American women in the United States, but few studies have examined differences in survival between these groups. The objective of this study was to examine racial/ethnic differences in survival after diagnosis with invasive cervical cancer in a population-based sample of patients while adjusting for patient and tumor characteristics and treatment types.
We identified 7267 women (4431 non-Hispanic Caucasians, 1830 Hispanic Caucasians, and 1006 non-Hispanic African Americans) diagnosed with primary invasive cervical cancer from 1992 to 1996 (with follow-up through 2000) from the Surveillance, Epidemiology and End Results (SEER) Program. Kaplan-Meier and Cox proportional hazards survival methods were used to assess differences in survival by race/ethnicity.
After adjusting for age at diagnosis, histology, stage, first course of cancer-directed treatment (surgery and radiation therapy), and SEER registry, Hispanic Caucasian women were at 26% decreased risk of death from any cause (hazard ratio (HR) = 0.74, 95% confidence interval (CI): 0.66-0.83) and non-Hispanic African American women were at 19% increased risk of death (HR = 1.19, 95% CI: 1.06-1.33) compared to non-Hispanic Caucasian women over the follow-up period.
Analysis of population-based SEER data indicates significant survival differences by race/ethnicity for women with invasive cervical cancer. Hispanic Caucasian women in SEER had improved survival compared to non-Hispanic Caucasian or non-Hispanic African American women.
在美国,西班牙裔女性宫颈癌的发病率高于非西班牙裔或非裔美国女性,但很少有研究探讨这些群体之间的生存差异。本研究的目的是在一个基于人群的患者样本中,在调整患者和肿瘤特征以及治疗类型的同时,研究浸润性宫颈癌诊断后的种族/民族生存差异。
我们从监测、流行病学和最终结果(SEER)计划中识别出1992年至1996年诊断为原发性浸润性宫颈癌(随访至2000年)的7267名女性(4431名非西班牙裔白人、1830名西班牙裔白人、1006名非西班牙裔非裔美国人)。采用Kaplan-Meier和Cox比例风险生存方法评估种族/民族的生存差异。
在调整诊断年龄、组织学、分期、首次癌症导向治疗(手术和放疗)以及SEER登记处后,在随访期间,西班牙裔白人女性任何原因导致的死亡风险降低26%(风险比(HR)=0.74,95%置信区间(CI):0.66-0.83),非西班牙裔非裔美国女性死亡风险增加19%(HR=1.19,95%CI:1.06-1.33),相比非西班牙裔白人女性。
基于人群的SEER数据分析表明,浸润性宫颈癌女性在种族/民族方面存在显著的生存差异。SEER中的西班牙裔白人女性与非西班牙裔白人或非西班牙裔非裔美国女性相比,生存率有所提高。